no image available Dickens & Co. "Breaking Down Barriers: EMA's Assessment of Pazopanib for a New Hope in Kidney Cancer Treatment" "Uncovering the EMA's findings on the efficacy and safety of pazopanib in advanced renal cell carcinoma patients" Price: 22.00€